Inspire Medical Systems Appoints New Chief Medical Officer
Ticker: INSP · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, medical-devices, personnel
TL;DR
Inspire Medical Systems just hired a new CMO from Medtronic to lead their sleep apnea tech.
AI Summary
Inspire Medical Systems, Inc. announced on July 18, 2024, the appointment of Dr. Steven J. Shulman as Chief Medical Officer. Dr. Shulman previously served as Chief Medical Officer at Medtronic's Cardiac Rhythm Management business. This appointment is part of the company's ongoing efforts to advance its innovative sleep apnea treatment.
Why It Matters
The appointment of a new Chief Medical Officer with experience from a major medical device company like Medtronic could signal a strategic push for Inspire Medical Systems in clinical development and market expansion.
Risk Assessment
Risk Level: low — The filing reports on a routine executive appointment and does not contain information that would immediately impact the company's financial standing or operations.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — Registrant
- Dr. Steven J. Shulman (person) — Appointed Chief Medical Officer
- Medtronic (company) — Previous employer of Dr. Shulman
- Cardiac Rhythm Management (company) — Dr. Shulman's former business unit at Medtronic
- July 18, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer at Inspire Medical Systems?
Dr. Steven J. Shulman has been appointed as the new Chief Medical Officer.
What was Dr. Steven J. Shulman's previous role?
Dr. Shulman previously served as Chief Medical Officer at Medtronic's Cardiac Rhythm Management business.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is July 18, 2024.
What is Inspire Medical Systems' primary business?
Inspire Medical Systems is involved in the Surgical & Medical Instruments & Apparatus industry, focusing on an innovative sleep apnea treatment.
What is the filing date of this 8-K report?
The filing date of this 8-K report is July 22, 2024.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-07-22 17:01:39
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
Filing Documents
- insp-20240718.htm (8-K) — 24KB
- 0001609550-24-000032.txt ( ) — 148KB
- insp-20240718.xsd (EX-101.SCH) — 2KB
- insp-20240718_lab.xml (EX-101.LAB) — 22KB
- insp-20240718_pre.xml (EX-101.PRE) — 13KB
- insp-20240718_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: July 22, 2024 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel 3